The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol
Open accessAbstract
IKZF1 gene deletions have been associated with a poor outcome in pediatric precursor B-cell acute lymphoblastic leukemia. To assess the prognostic relevance of IKZF1 deletions for patients treated on Berlin-Frankfurt-Münster Study Group trial ALL-BFM 2000, we screened 694 diagnostic acute lymphoblastic leukemia samples by Multiplex Ligation-dependent Probe Amplification. Patients whose leukemic cells bore IKZF1 deletions had a lower 5-year event-free survival (0.69±0.05 vs. 0.85±0.01; P<0.0001) compared to those without, mainly due to a higher cumulative incidence of relapses (0.21±0.04 vs. 0.10±0.01; P=0.001). Although IKZF1 deletions were significantly associated with the P2RY8-CRLF2 rearrangement, their prognostic value was found to be independent from this association. Thus, IKZF1 deletion is an independent predictor of treatment outcome and a strong candidate marker for integration in future treatment stratification strategies on ALL-BFM protocols. Clinicaltrials.gov identifier: NCT00430118.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia
Mullighan, C. G., Su, X., Zhang, J., Radtke, I., Phillips, L. A. A., Miller, C. B., Ma, J., Liu, W., Cheng, C., Schulman, B. A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808253 · Cited by 1,422
BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
Mullighan, C. G., Miller, C. B., Radtke, I., Phillips, L. A., Dalton, J., Ma, J., White, D., Hughes, T. P., Le Beau, M. M., Pui, C.-H., et al. (2008) · Nature · doi:10.1038/nature06866 · Cited by 1,072
Cited by
Beldjord, K., Chevret, S., Asnafi, V., Huguet, F., Boulland, M.-L., Leguay, T., Thomas, X., Cayuela, J.-M., Grardel, N., Chalandon, Y., et al. (2014) · Blood · doi:10.1182/blood-2014-01-547695 · Cited by 330
Lilljebjörn, H., Henningsson, R., Hyrenius-Wittsten, A., Olsson, L., Orsmark-Pietras, C., von Palffy, S., Askmyr, M., Rissler, M., Schrappe, M., Cario, G., et al. (2016) · Nature Communications · doi:10.1038/ncomms11790 · Cited by 314
Self-citationStanulla, M., Dagdan, E., Zaliova, M., Möricke, A., Palmi, C., Cazzaniga, G., Eckert, C., te Kronnie, G., Bourquin, J.-P., Bornhauser, B., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.3617 · Cited by 303
Self-citationPhiladelphia chromosome–like acute lymphoblastic leukemia
Tasian, S. K., Loh, M. L., & Hunger, S. P. (2017) · Blood · doi:10.1182/blood-2017-06-743252 · Cited by 296
van der Veer, A., Waanders, E., Pieters, R., Willemse, M. E., Van Reijmersdal, S. V., Russell, L. J., Harrison, C. J., Evans, W. E., van der Velden, V. H. J., Hoogerbrugge, P. M., et al. (2013) · Blood · doi:10.1182/blood-2012-10-462358 · Cited by 289
Metadata
- Authors
- Dorge, P., Meissner, B., Zimmermann, M., Moricke, A., Schrauder, A., Bouquin, J.-P., Schewe, D., Harbott, J., Teigler-Schlegel, A., Ratei, R., Ludwig, W.-D., Koehler, R., Bartram, C. R., Schrappe, M., Stanulla, M., & Cario, G.
- Venue
- Haematologica
- Published
- 2012-08-08
- Volume
- 98
- Issue
- 3
- Pages
- 428-432
- ISSN
- 0390-6078 (ISSN-L)
- 1592-8721
- OpenAlex
- W2089583676
- Cited by
- 162
- References
- 2
- FWCI
- 13.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol. https://app.cochat.ai/papers/10.3324/haematol.2011.056135
- The paper
- Dorge, P., Meissner, B., Zimmermann, M., Moricke, A., Schrauder, A., Bouquin, J.-P., Schewe, D., Harbott, J., Teigler-Schlegel, A., Ratei, R., Ludwig, W.-D., Koehler, R., Bartram, C. R., Schrappe, M., Stanulla, M., & Cario, G. (2013). IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol. Haematologica. https://doi.org/10.3324/haematol.2011.056135
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.